Agilon Health

Agilon Health, Inc. is a healthcare company, enables primary care physicians (PCPs) to be agents in the communities they serve. It provides healthcare for seniors across communities throughout the United States and has created an agilon Platform, which is a Total Care Model for community-based physicians. The firm serves a Total Care Model which focuses exclusively on Medicare and manages the comprehensive healthcare needs of its members through subscription-like member per month arrangements with health plans or directly with the Centers for Medicare and Medicaid services. The company was founded in 2016 and is headquartered in Austin, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Agilon Health reports strong 2022 performance and optimistic growth outlook

Agilon Health had a successful 2022, with strong financial performance and a focus on transforming healthcare through empowering primary care doctors. The company is optimistic about future growth, managing challenges in margins and financial management while leveraging opportunities in partnerships and operational efficiency.

Agilon Health triples Q1 earnings, eyes growth through partnerships

Agilon Health (AGL) delivered robust Q1 2023 results, maintaining outlook and confidence in clinical programs for high-cost patients and new partnerships.
Effective management of costs and revenues, alongside strategic acquisitions and partnerships, underpin the company's growth trajectory.
Challenges include margin impacts from external factors and managing costs associated with market expansion, balanced by opportunities in network growth and market transition.
The company's performance, strengths, challenges, and opportunities collectively shape its strategic direction towards sustained growth and operational excellence.

Agilon Health excels in Q2 2023, eyes growth opportunities

Agilon Health's strong financial performance in Q2 2023 underscores its operational excellence and growth potential. While challenges like revenue projections and medical margin variations exist, the company's strategic focus on risk adjustment and payer partnerships presents significant opportunities for future success.

Agilon Health reports strong Q3 performance, eyes growth opportunities

Agilon Health's Q3 2023 performance reflects robust growth in partner markets and revenue, supported by a unique model driving clinical and financial success.
While facing challenges in cash flow and benefit pullbacks, the company is well-positioned to leverage opportunities for growth and operational enhancement in '24.
Strategic decisions like selling the Hawaii business and focusing on core markets demonstrate a commitment to sustainable growth and operational efficiency.

Agilon Health addresses challenges, focuses on growth opportunities in 2024

Agilon Health faces challenges with medical margins but is making progress on their 2024 performance action plan to drive improvement.
The company is focusing on data visibility, quality partnerships, and efficiency gains to navigate the dynamic utilization environment and achieve growth.
Despite higher cash burn in 2024, Agilon anticipates positive cash flow from 2025 onwards if they meet their guidance and address payer negotiations.
Opportunities lie in a measured growth approach, cohort progression, and tuning payer arrangements to reflect the value provided by Agilon's services.

Agilon Health reports strong Q1 growth, navigates healthcare challenges

Agilon Health's Q1 '24 performance showcased growth in membership, revenue, medical margin, and adjusted EBITDA, despite challenges in cost trends and utilization.
The company's strategic focus on value-based care partnerships, data analytics, and operational efficiency positions them well for future growth and profitability.
While facing challenges in cost management and contract negotiations, Agilon Health is actively pursuing opportunities in sustainable payer contracts, technology enhancements, and benefit expansions.

Agilon Health reports strong Q2 performance and strategic growth outlook

Agilon Health's Q2 2024 earnings call reflects robust performance, operational strengths, strategic challenges, and growth opportunities in the evolving healthcare landscape.
The company's focus on refining payer relationships, enhancing data visibility, and driving operational efficiency positions it well for sustained success and market expansion.
Despite facing financial challenges and navigating payer dynamics, Agilon Health's proactive approach to innovation and leadership changes signals a commitment to long-term growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Agilon Health, Inc. engages in providing healthcare services. It also provides the technology, people, capital, process, and access to a peer network of primary care physicians. The company was founded by Ronald A. Williams and Veeral Desai in 2016 and is headquartered in Austin, TX.

agilon health, Inc. (NYSE:AGL ) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Sandy Draper - Guggenheim Whit Mayo - SVB Securities Brian Tanquilut - Jefferies David Larsen - BTIG George Hill - Deutsche Bank Jamie Perse - Goldman Sachs Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Lisa Gill - JP Morgan Ryan Daniels - William Blair Sean Dodge - RBC Stephen Baxter - Wells Fargo Operator Hello, everybody, and welcome to the agilon health Fourth Quarter 2022 earnings call. My name is Sam, and I'll be coordinating your call today.

agilon health, Inc. (AGL) Q4 2022 Earnings Call Transcript

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter and fiscal year ended December 31, 2022. Fourth Quarter and Fiscal Year 2022 Results: Total revenue of $690 million increased 49% during the fourth quarter compared to $463 million in the fourth quarter 2021. For the fiscal year 2022, total revenue of $2.71 billion increased 48% compared to $1.

agilon health Reports Fourth Quarter and Fiscal Year 2022 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced it has acquired mphrX, a leading provider of value-based care technology and interoperability solutions. As a result of the transaction, mphrX will become a wholly owned subsidiary of agilon health.

agilon health Announces Acquisition of mphrX, a Leading Healthcare Technology Company

SELINSGROVE, Pa. & AUSTIN, Texas--(BUSINESS WIRE)--Family Practice Center, PC (FPC), Central Pennsylvania's largest independent primary care physician group, today announced that it has formed a new partnership with agilon health inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities.

Family Practice Center (FPC) Partners with agilon health to Deliver New Level of Value-Based Care for Central Pennsylvanians

AUSTIN, Texas--(BUSINESS WIRE)--agilon health inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that Diana McKenzie has been named an independent board director. McKenzie brings more than 30 years of leadership experience growing, scaling, and transforming global businesses in the healthcare and software industries.

agilon health Names Diana McKenzie to Board of Directors

COLUMBUS, Ohio--(BUSINESS WIRE)--Central Ohio Primary Care (COPC), Greater Columbus' premier innovative, collaborative, and data-driven physician led organization, has teamed up with longstanding partner agilon health, inc.

Central Ohio Primary Care (COPC) and agilon health Partner with COPE Health Solutions to Launch Primary Care Advanced Practice Provider (APP) Fellowship Program

LEXINGTON, Ky. & AUSTIN, Texas--(BUSINESS WIRE)--Lexington Clinic announced today that it has formed a new partnership with agilon health inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, that will transition its primary care delivery system to a full-risk, value-based care model to enhance outcomes and quality of care for Central Kentucky Medicare patients beginning in 2024.

Lexington Clinic, Central Kentucky's Oldest and Largest Multi-Specialty Physician Group, Partners with agilon health to Introduce Value-based Primary Care Delivery

AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2022 after the market closes on Wednesday, March 1, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.

agilon health Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results

AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, has released new data examining the impact of its full-risk, Total Care Model (agilon model) among Medicare Advantage (MA) patients with diabetes.

Diabetes Patients See Significant Benefit from Value-Based, Total Care Model, According to New Data from agilon health

I believe the current US healthcare setup is not ideal for stakeholders. The agilon health platform offers a compelling value proposition to stakeholders.

agilon health: Long-Term Sustainable Business Model To Address The Needs Of U.S. Healthcare

AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference including a fireside chat presentation on Monday, January 9 at 12:45PM Eastern Time.

agilon health to Participate in the 41st Annual J.P. Morgan Healthcare Conference

agilon health, inc. is unable to return back to previous highs, losing support and buying volume. This, despite a reasonably strong quarter of growth.

agilon health: Back To Long-Term Range, Despite Underlying Market Growth

Brookfield Renewable Partners

Cameco

California Resources

Janus Detr Strt Shs Organics

It's working toward speeding up the global transition to cleaner energy.

This Dividend Stock Is Pouncing on a "Once-in-a-Generation" Opportunity

agilon health, inc. (NYSE:AGL ) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - SVB Securities Sean Dodge - RBC Capital Markets Taji Phillips - Jefferies Stephen Baxter - Wells Fargo Jamie Perse - Goldman Sachs Gary Taylor - Cowen Operator Hello, and a warm welcome to today's agilon health Third Quarter 2022 Earnings Call.

agilon health, inc. (AGL) Q3 2022 Earnings Call Transcript

Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc.

agilon health Reports Third Quarter 2022 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2022 after the market closes on Thursday, November 3, 2022, and host a conference call at 5:00 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 927-1758 for U.S. participants and +1 (929) 526-1599 for international

agilon health Sets Date to Report Third Quarter 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Michael Smith will retire from agilon health's board of directors after more than five years of service. Upon Smith's retirement, Jeff Schwaneke has been elected as an independent board member effective immediately. Schwaneke is the former Executive Vice President, Health Care Enterprises for Centene Corporation, a Fortune 5

agilon health Announces Retirement and New Appointment to its Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today released its inaugural Total Care, Healthier Communities Impact Report highlighting the company's Environmental, Social, and Governance (ESG) performance for 2021. The impact report reflects agilon health's vision and commitment with its physician partners to transforming health care in 100+ communities through value-based primary care. "E

agilon health Releases Inaugural ESG Report Launching Total Care, Healthier Communities Impact Strategy

agilon health, inc. (NYSE:AGL ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Matthew Gillmor – Vice President of Investor Relations Steve Sell – Chief Executive Officer Tim Bensley – Chief Financial Officer Conference Call Participants Lisa Gill – JPMorgan Justin Lake – Wolfe Research Stephen Baxter – Wells Fargo Taji Phillips – Jefferies Whit Mayo – SVB Securities Adam Ron – Bank of America Jack Senft – William Blair Gary Taylor – Cowen George Hill – Deutsche Bank Operator Good afternoon.

agilon health, inc.'s (AGL) CEO Steve Sell on Q2 2022 Results - Earnings Call Transcript

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced results for the second quarter ended June 30, 2022. Second Quarter 2022 Results: Total revenue of $670 million increased 34% during the second quarter compared to $499 million in the second quarter 2021. Normalized for the timing of a retroactive group contract in the prior year, revenue growth in the second quarter 2022 would have been 42%

agilon health Reports Second Quarter 2022 Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2022 after the market closes on Thursday, August 4, 2022, and host a conference call at 5:00 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (844) 200-6205 for U.S. participants and +1 (646) 904-5544 for international p

agilon health Sets Date to Report Second Quarter 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced the appointment of Denise Zamore as the company's first Chief Legal Officer and Secretary to the agilon health Board of Directors effective August 1, 2022. Zamore will become a member of the executive leadership team, reporting to Steve Sell, CEO, and will lead the company's legal function. “By creating a chief legal officer position o

agilon health Appoints Denise Zamore as Chief Legal Officer

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the William Blair 42nd Annual Growth Stock Conference, including a presentation on Wednesday, June 8 at 9:40 AM Eastern Time. Interested investors and other parties may listen to simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor relations web

agilon health to Participate in the William Blair 42nd Annual Growth Stock Conference

agilon health went public in April 2021, raising approximately $1 billion in an IPO. The firm provides health care services to Medicare Advantage patients in the United States.

News for Agilon Health Stock (AGL)